Refreshing results…
T-cell Lymphoma and Secondary Primary Malignancy Risk After Commercial CAR T-cell Therapy
UploadAuthor Correction: Decade-long leukaemia remissions with persistence of CD4+ CAR T cells
UploadPublisher Correction: Potentiating adoptive cell therapy using synthetic IL-9 receptors
UploadMonitoring Therapeutic Response to Anti-FAP CAR T Cells Using [18F]AlF-FAPI-74
UploadPotentiating adoptive cell therapy using synthetic IL-9 receptors
Download from www.nature.comDecade-long leukaemia remissions with persistence of CD4+ CAR T cells
Download from www.nature.comCAR T cells produced in vivo to treat cardiac injury
UploadThe Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple Myeloma
UploadNovel Redirected T Cell Immunotherapies for Advanced Prostate Cancer
Download from aacrjournals.orgAntigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cells
Download from www.nature.comCRISPR-engineered T cells in patients with refractory cancer
UploadMissing publications? Search for publications with a matching author name.